Lifestyle factors as mediators in the relationship between depression, obesity, and blood pressure in the post-pandemic era
Sheng-Hao Zuo , Chen-Yang Liu , Rui-Yu Wang , Gui-Lin Hu , Yue Sun , Ming-Ke Chang , Zi-Yue Man , Hao Jia , Teng Zhang , Ming-Fei Du , Xi Zhang , Yang Wang , Jian-Jun Mu
Metabolism and Target Organ Damage ›› 2025, Vol. 5 ›› Issue (3) : 39
Lifestyle factors as mediators in the relationship between depression, obesity, and blood pressure in the post-pandemic era
Aim: The post-COVID-19 pandemic era has witnessed changes in psychological states and lifestyles. This study aims to explore the associations between depression, obesity, and hypertension, and further assess the mediating effects of lifestyle factors such as sleep duration, working hours, and physical activity on these disease relationships.
Methods: Using data from the National Health and Nutrition Examination Survey (NHANES) from 2005 to 2023, we calculated long-term trends in depression, sleep duration, working hours, metabolic equivalent of exercise, obesity, and blood pressure. Data from 42,395 (sleep duration), 23,101 (working hours), and 20,435 participants (physical activity) were used to evaluate the relationships between lifestyle factors, depression, obesity, and blood pressure.
Results: Between 2021 and 2023, the average depression score in the U.S. increased to 4.13 (4.74), with prevalence rising to 13.2%. Over the past 18 years, national body mass index (BMI), waist circumference (WC), waist-to-height ratio (WHtR), and sleep duration increased (P < 0.001), while working hours decreased (P < 0.001) and physical activity declined post-pandemic (P < 0.001). Depression was positively correlated with BMI, WC, WHtR, and diastolic blood pressure (DBP) (P < 0.0001), and negatively correlated with systolic blood pressure, sleep duration, and physical activity (P < 0.0001). Sleep duration and physical activity mediated 1.72%-4.52% and 9.28%-14.79%, respectively, of the positive correlation between depression and obesity. Physical activity mediated 5.49%-9.96% of the positive correlation between depression and DBP. No mediating effect of working hours was found between depression and obesity or blood pressure (P = 0.500-0.936).
Conclusion: In the post-COVID-19 pandemic era, this study advocates for increased attention to lifestyle factors. Moderate extensions in sleep duration, reductions in working hours, and increased physical activity may help alleviate the burdens of depression, obesity, and blood pressure.
Depression / lifestyle / sleep duration / worktime / physical activity / obesity / blood pressure / COVID-19
| [1] |
2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.Lancet2024;403:2133-61 PMCID:PMC11122111 |
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
Mazza MG, De Lorenzo R, Conte C, et al; COVID-19 BioB Outpatient Clinic Study group. Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors. Brain Behav Immun. 2020;89:594-600. PMCID:PMC7390748 |
| [6] |
|
| [7] |
|
| [8] |
Koskinas KC, Van Craenenbroeck EM, Antoniades C, et al; ESC Scientific Document Group. Obesity and cardiovascular disease: an ESC clinical consensus statement. Eur Heart J. 2024;45:4063-98. |
| [9] |
NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults.Lancet2024;403:1027-50 PMCID:PMC7615769 |
| [10] |
McEvoy JW, McCarthy CP, Bruno RM, et al; ESC Scientific Document Group. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. Eur Heart J. 2024;45:3912-4018. |
| [11] |
Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants.Lancet2021;398:957-80 PMCID:PMC8446938 |
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
Prevention CfDCa. NHANES survey methods and analytic guidelines. Available https://wwwn.cdc.gov/nchs/nhanes/analyticguidelines.aspx. [Last accessed on 11 Aug 2025]. |
| [23] |
Levis B, Benedetti A, Thombs BD; DEPRESsion Screening Data (DEPRESSD) Collaboration. Accuracy of patient health questionnaire-9 (PHQ-9) for screening to detect major depression: individual participant data meta-analysis. BMJ. 2019;365:l1476. PMCID:PMC6454318 |
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
| [44] |
|
| [45] |
|
| [46] |
|
| [47] |
|
| [48] |
|
| [49] |
|
| [50] |
|
| [51] |
|
| [52] |
|
| [53] |
|
| [54] |
|
| [55] |
|
| [56] |
|
| [57] |
|
| [58] |
|
| [59] |
|
| [60] |
|
/
| 〈 |
|
〉 |